Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-240
Closed -$78.6K 128
2025
Q4
$78.6K Buy
+240
New +$76.1K 0.02% 158
2025
Q1
Sell
-445
Closed -$116K 117
2024
Q4
$116K Sell
445
-6,929
-94% -$2.06M 0.04% 120
2024
Q3
$2.38M Buy
7,374
+259
+4% +$84.7K 0.78% 43
2024
Q2
$2.22M Buy
7,115
+455
+7% +$134K 0.79% 43
2024
Q1
$1.89M Buy
+6,660
New +$1.95M 0.7% 46
2021
Q3
Sell
-75
Closed -$18K 108
2021
Q2
$18K Buy
+75
New +$18.4K 0.01% 197
2020
Q3
Sell
-75
Closed -$18K 89
2020
Q2
$18K Buy
+75
New +$17.1K 0.01% 158

Other funds holding AMGN

Modus Advisors's AMGN Position: Q1 2026 in Review

Modus Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 240 shares — an estimated $78.6K sold.

Modus Advisors first reported a position in AMGN in Q2 2020 and held it in 7 quarters. The position peaked at $2.38M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Modus Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Modus Advisors sold 240 Amgen shares in Q1 2026, an estimated $78.6K.
  • Modus Advisors first reported a position in Amgen in Q2 2020 and held it in 7 quarters.
  • Modus Advisors's Amgen position peaked at $2.38M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Modus Advisors's 13F filing for Q1 2026, filed 4 May 2026.